Of French and Italian researchers have developed an effective protection against the bacterium that causes tuberculosis in mice. Although results are preliminary, they raise the hope of tomorrow to have a more effective vaccine against the disease responsible for death of 1.5 million per year.
80% of TB patients live in sub-Saharan Africa. The limitations of BCG against pulmonary tuberculosis
Tuberculosis is one of the most prevalent diseases in the world. It is due to infection by the mycobacterium Mycobacterium tuberculosis , affecting one third of world population. Each year, nearly 9 million people developed tuberculosis and nearly 1.5 million people die. About 80% of patients live in sub-Saharan Africa; it has not disappeared in France. Continue reading “Towards a more effective vaccine against tuberculosis”